The effects of coconut oil in metabolic syndrome
Not Applicable
- Conditions
- metabolic syndrome.metabolic syndromeE88.81
- Registration Number
- IRCT20131125015536N11
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
20 to 50 years old men and women diagnosed as metabolic syndrome Giving informed consent for participation in the study
Exclusion Criteria
The history of any type of medical or surgical disease, drinking alcohol, history of coconut oil intolerance, pregnancy or breastfeeding, smoking or any type of drug, the use of any drug or supplement that affects metabolic syndrome indices. , Compliance with a particular diet or weight loss program, changes in the last three months and professional exercise, a patient's unwillingness to continue to study, hypersensitivity or intolerance to the consumption of coconut oil
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood pressure. Timepoint: Before and after 4 weeks of intervention. Method of measurement: Digital barometer.;Serum Fasting blood glucose level. Timepoint: Before and after 4 weeks of intervention. Method of measurement: Enzymatic Kit.;Serum triglyceride level. Timepoint: Before and after 4 weeks of intervention. Method of measurement: Enzymatic Kit.;Serum HDL-C level. Timepoint: Before and after 4 weeks of intervention. Method of measurement: Enzymatic Kit.;Serum Asymmetric D-methyl arginine level. Timepoint: Before and after 4 weeks of intervention. Method of measurement: Eliza kit.;Waist circumference. Timepoint: Before and after 4 weeks of intervention. Method of measurement: observation.;Serum brain derived neurotrophic factor level. Timepoint: Before and after 4 weeks of intervention. Method of measurement: Eliza kit.
- Secondary Outcome Measures
Name Time Method Body composition analysis. Timepoint: Before and after 4 weeks of intervention. Method of measurement: Bio-electrical impedance analysis.;Serum lipid profile. Timepoint: Before and after 4 weeks of intervention. Method of measurement: Enzymatic Kit.;Serum insulin level. Timepoint: Before and after 4 weeks of intervention. Method of measurement: Eliza kit.;Serum malondialdehyde level. Timepoint: Before and after 4 weeks of intervention. Method of measurement: MDA assay Kit (colorimetrically or fluorometrically).;Serum total antioxidant capacity. Timepoint: Before and after 4 weeks of intervention. Method of measurement: TAC assay Kit (photometrically).